Synthesis of Nano-Paramagnetic Oleuropein to Induce KRAS Over-Expression: A New Mechanism to Inhibit AGS Cancer Cells
Human gastric adenocarcinoma (AGS) is one of the most common malignant cancers worldwide. The present study aimed to transfer oleuropein into cancer cells using synthetic paramagnetic nanoparticles and study their effect on the AGS (ATCC CRL1739™) cell line. Paramagnetic nano-oleuropein was synthesi...
Saved in:
Published in | Medicina (Kaunas, Lithuania) Vol. 55; no. 7; p. 388 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
MDPI
19.07.2019
MDPI AG |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Human gastric adenocarcinoma (AGS) is one of the most common malignant cancers worldwide. The present study aimed to transfer oleuropein into cancer cells using synthetic paramagnetic nanoparticles and study their effect on the AGS (ATCC
CRL1739™) cell line.
Paramagnetic nano-oleuropein was synthesized using four-stage co-precipitation by developing NH-connected bridges and was evaluated by EDS, SEM and FTIR methods. Different concentrations of magnetic oleuropein (0, 0.15, 0.45, 1.37, 4.12, 12.35, 37.04, 111.11, 333.33, 1000 µg/mL) were used to treat the AGS cell line in a completely randomized design using a statistical framework with three replicates. The relative expression rate of miR-200 and KRAS oncogenes was evaluated using real-time PCR. The inhibition rate of the AGS cells was assessed using the MTT test at 24, 48 and 72 h intervals.
The results showed that there was a significant difference between the inhibition rates of magnetic nano-oleuropein at IC50-24h (23.6 µg/mL), IC50-48h (15.2 µg/mL) and IC50-72h (9.2 µg/mL). Real-time PCR indicated that the relative expression of KRAS and miR-200 genes was highest at IC50 at these intervals.
Magnetic nano-oleuropein can be subjected to objective testing and clinical evaluations as a natural antioxidant to prevent and treat gastric adenocarcinoma. |
---|---|
AbstractList | Background and objectives: Human gastric adenocarcinoma (AGS) is one of the most common malignant cancers worldwide. The present study aimed to transfer oleuropein into cancer cells using synthetic paramagnetic nanoparticles and study their effect on the AGS (ATCC® CRL1739™) cell line. Materials and Methods: Paramagnetic nano-oleuropein was synthesized using four-stage co-precipitation by developing NH-connected bridges and was evaluated by EDS, SEM and FTIR methods. Different concentrations of magnetic oleuropein (0, 0.15, 0.45, 1.37, 4.12, 12.35, 37.04, 111.11, 333.33, 1000 µg/mL) were used to treat the AGS cell line in a completely randomized design using a statistical framework with three replicates. The relative expression rate of miR-200 and KRAS oncogenes was evaluated using real-time PCR. The inhibition rate of the AGS cells was assessed using the MTT test at 24, 48 and 72 h intervals. Results: The results showed that there was a significant difference between the inhibition rates of magnetic nano-oleuropein at IC50-24h (23.6 µg/mL), IC50-48h (15.2 µg/mL) and IC50-72h (9.2 µg/mL). Real-time PCR indicated that the relative expression of KRAS and miR-200 genes was highest at IC50 at these intervals. Conclusions: Magnetic nano-oleuropein can be subjected to objective testing and clinical evaluations as a natural antioxidant to prevent and treat gastric adenocarcinoma. Background and objectives: Human gastric adenocarcinoma (AGS) is one of the most common malignant cancers worldwide. The present study aimed to transfer oleuropein into cancer cells using synthetic paramagnetic nanoparticles and study their effect on the AGS (ATCC ® CRL1739™) cell line. Materials and Methods: Paramagnetic nano-oleuropein was synthesized using four-stage co-precipitation by developing NH-connected bridges and was evaluated by EDS, SEM and FTIR methods. Different concentrations of magnetic oleuropein (0, 0.15, 0.45, 1.37, 4.12, 12.35, 37.04, 111.11, 333.33, 1000 µg/mL) were used to treat the AGS cell line in a completely randomized design using a statistical framework with three replicates. The relative expression rate of miR-200 and KRAS oncogenes was evaluated using real-time PCR. The inhibition rate of the AGS cells was assessed using the MTT test at 24, 48 and 72 h intervals. Results: The results showed that there was a significant difference between the inhibition rates of magnetic nano-oleuropein at IC50-24h (23.6 µg/mL), IC50-48h (15.2 µg/mL) and IC50-72h (9.2 µg/mL). Real-time PCR indicated that the relative expression of KRAS and miR-200 genes was highest at IC50 at these intervals. Conclusions: Magnetic nano-oleuropein can be subjected to objective testing and clinical evaluations as a natural antioxidant to prevent and treat gastric adenocarcinoma. Human gastric adenocarcinoma (AGS) is one of the most common malignant cancers worldwide. The present study aimed to transfer oleuropein into cancer cells using synthetic paramagnetic nanoparticles and study their effect on the AGS (ATCC CRL1739™) cell line. Paramagnetic nano-oleuropein was synthesized using four-stage co-precipitation by developing NH-connected bridges and was evaluated by EDS, SEM and FTIR methods. Different concentrations of magnetic oleuropein (0, 0.15, 0.45, 1.37, 4.12, 12.35, 37.04, 111.11, 333.33, 1000 µg/mL) were used to treat the AGS cell line in a completely randomized design using a statistical framework with three replicates. The relative expression rate of miR-200 and KRAS oncogenes was evaluated using real-time PCR. The inhibition rate of the AGS cells was assessed using the MTT test at 24, 48 and 72 h intervals. The results showed that there was a significant difference between the inhibition rates of magnetic nano-oleuropein at IC50-24h (23.6 µg/mL), IC50-48h (15.2 µg/mL) and IC50-72h (9.2 µg/mL). Real-time PCR indicated that the relative expression of KRAS and miR-200 genes was highest at IC50 at these intervals. Magnetic nano-oleuropein can be subjected to objective testing and clinical evaluations as a natural antioxidant to prevent and treat gastric adenocarcinoma. |
Author | Zaefizadeh, Mohammad Yari, Reza Salehzadeh, Ali Barzegar, Farhad |
AuthorAffiliation | 1 Department of Biology, Rasht Branch, Islamic Azad University, Rasht, Iran 3 Department of Biology, Borujerd Branch, Islamic Azad University, Borujerd, Iran 2 Department of Biology, Ardabil Branch, Islamic Azad University, Ardabil, Iran |
AuthorAffiliation_xml | – name: 1 Department of Biology, Rasht Branch, Islamic Azad University, Rasht, Iran – name: 2 Department of Biology, Ardabil Branch, Islamic Azad University, Ardabil, Iran – name: 3 Department of Biology, Borujerd Branch, Islamic Azad University, Borujerd, Iran |
Author_xml | – sequence: 1 givenname: Farhad surname: Barzegar fullname: Barzegar, Farhad organization: Department of Biology, Rasht Branch, Islamic Azad University, 31567-56157 Rasht, Iran – sequence: 2 givenname: Mohammad surname: Zaefizadeh fullname: Zaefizadeh, Mohammad email: mzaefi@iauardabil.ac.ir organization: Department of Biology, Ardabil Branch, Islamic Azad University, 56199-11367 Ardabil, Iran. mzaefi@iauardabil.ac.ir – sequence: 3 givenname: Reza orcidid: 0000-0003-1604-1889 surname: Yari fullname: Yari, Reza organization: Department of Biology, Borujerd Branch, Islamic Azad University, 14676-86831 Borujerd, Iran – sequence: 4 givenname: Ali orcidid: 0000-0003-4238-0999 surname: Salehzadeh fullname: Salehzadeh, Ali organization: Department of Biology, Rasht Branch, Islamic Azad University, 31567-56157 Rasht, Iran |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31330954$$D View this record in MEDLINE/PubMed |
BookMark | eNpdkc1v1DAQxS1URD_gzgn5yCXgzzjmgLRalbKidBELZ8txJruuEnuxk0L_ewxbqpaTLc-b3xvPO0VHIQZA6CUlbzjX5O0InXc-WCmJIrxpnqATWoum0lSIowf3Y3Sa8zUhnEnFnqFjTjknWooTNG9uw7SD7DOOPb6yIVZfbLKj3QaYvMPrAeYU9-ADniJehW52gD99XWzw-gZSdf5rnyBnH8M7vMBX8BN_BrezwefxoN_51k94cbHBSxscJLyEYcjP0dPeDhle3J1n6PuH82_Lj9Xl-mK1XFxWTtRsqiQ0suulbmrZacuE1LZXCqjsJKFdSxpddD1vGRcCGHPQgmqF7iRwTZVy_AytDtwu2muzT3606dZE683fh5i2xqbyzQGMY7yVXPWa0kZIJTUFUKyRbd2RVjteWO8PrP3clr07CFOywyPo40rwO7ONN6aum8JUBfD6DpDijxnyZEafXVmHDRDnbBhTxZoKqouUHKQuxZwT9Pc2lJg_yZv_ky8trx6Od9_wL2r-G5ETrSY |
CitedBy_id | crossref_primary_10_1007_s00210_024_03182_9 crossref_primary_10_1007_s11033_023_08773_y crossref_primary_10_1007_s40199_024_00512_3 crossref_primary_10_1016_j_ijbiomac_2024_130527 crossref_primary_10_1007_s12011_020_02138_3 crossref_primary_10_1007_s11033_020_05251_7 crossref_primary_10_1002_ptr_7325 crossref_primary_10_1007_s10876_021_02023_6 crossref_primary_10_3390_antiox9020149 crossref_primary_10_1080_24701556_2020_1792495 crossref_primary_10_1080_17425247_2021_1932813 crossref_primary_10_1590_0034_737x202067040009 |
Cites_doi | 10.3390/ijms151018508 10.1186/1471-2407-7-80 10.1021/jp300585d 10.3892/mmr.2015.3266 10.1016/j.neo.2017.02.012 10.1016/j.cell.2009.11.026 10.1016/j.gde.2005.08.005 10.1242/jcs.182873 10.1074/jbc.M410670200 10.1261/rna.2183803 10.1038/onc.2017.377 10.1002/(SICI)1096-9896(199903)187:4<433::AID-PATH273>3.0.CO;2-E 10.3892/mmr.2015.3816 10.1016/S1470-2045(10)70130-3 10.1186/1756-8722-2-18 10.1002/jcb.26754 10.1186/1471-2407-8-255 10.1517/17425247.2014.924501 10.3797/scipharm.0912-18 10.1016/j.bbrc.2005.06.161 10.3748/wjg.v12.i3.354 10.1007/s10876-017-1172-6 10.4178/epih/e2015006 10.1016/S0960-9776(11)70297-1 10.18632/oncotarget.5198 10.1097/PPO.0b013e318258b771 10.1093/carcin/bgi223 10.1158/1535-7163.MCT-06-0433 |
ContentType | Journal Article |
Copyright | 2019 by the authors. 2019 |
Copyright_xml | – notice: 2019 by the authors. 2019 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM DOA |
DOI | 10.3390/medicina55070388 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1648-9144 1010-660X |
ExternalDocumentID | oai_doaj_org_article_c23b537f9118457591ee7285b6d0b9c3 10_3390_medicina55070388 31330954 |
Genre | Journal Article |
GroupedDBID | 0R~ 0SF 29M 2WC 4.4 457 53G 5GY 5VS 7X7 8FI 8FJ AACTN AADQD AAEDT AAFWJ AAIKJ ABMAC ABUWG ACGFS ADBBV ADEZE AFKRA AFPKN AFZYC AGHFR AHDRD ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV BENPR CCPQU CGR CUY CVF DIK ECM EIF F5P FDB FYUFA GROUPED_DOAJ HMCUK HYE IAO KQ8 MODMG NPM O9- OK1 PGMZT PIMPY RPM UKHRP XSB AAYXX CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c462t-5e85df59865d9a2459af77e15d501db089c46f3b2344e22cebe7b49d5e39177c3 |
IEDL.DBID | RPM |
ISSN | 1648-9144 1010-660X |
IngestDate | Tue Oct 22 15:13:25 EDT 2024 Tue Sep 17 21:21:51 EDT 2024 Fri Aug 16 01:11:36 EDT 2024 Fri Aug 23 05:00:37 EDT 2024 Sat Sep 28 08:35:04 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | miR-200 oncogene nano-oleuropein AGS Cancer oleuropein real-time PCR K-Ras |
Language | English |
License | Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c462t-5e85df59865d9a2459af77e15d501db089c46f3b2344e22cebe7b49d5e39177c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-4238-0999 0000-0003-1604-1889 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681187/ |
PMID | 31330954 |
PQID | 2271841419 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_c23b537f9118457591ee7285b6d0b9c3 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6681187 proquest_miscellaneous_2271841419 crossref_primary_10_3390_medicina55070388 pubmed_primary_31330954 |
PublicationCentury | 2000 |
PublicationDate | 20190719 |
PublicationDateYYYYMMDD | 2019-07-19 |
PublicationDate_xml | – month: 7 year: 2019 text: 20190719 day: 19 |
PublicationDecade | 2010 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland |
PublicationTitle | Medicina (Kaunas, Lithuania) |
PublicationTitleAlternate | Medicina (Kaunas) |
PublicationYear | 2019 |
Publisher | MDPI MDPI AG |
Publisher_xml | – name: MDPI – name: MDPI AG |
References | Muller (ref_7) 2009; 139 Fu (ref_5) 2015; 12 Payne (ref_6) 2005; 26 Going (ref_11) 1999; 187 Abtin (ref_18) 2018; 119 Miska (ref_15) 2005; 15 Ambros (ref_14) 2003; 9 Ikediobi (ref_9) 2006; 5 Sarbishegi (ref_21) 2014; 18 Kim (ref_2) 2015; 37 Yan (ref_24) 2015; 11 Hosseinian (ref_28) 2015; 5 Choudhuri (ref_29) 2005; 280 Claes (ref_12) 2010; 11 Hobbs (ref_13) 2016; 129 Poonam (ref_26) 2012; 116 Iorio (ref_16) 2011; 3 Hamdi (ref_19) 2005; 334 Song (ref_25) 2015; 6 Crew (ref_1) 2006; 12 Khalili (ref_4) 2017; 28 Kunej (ref_17) 2012; 18 Laurent (ref_27) 2014; 11 Barbaro (ref_3) 2014; 15 ref_22 Liu (ref_23) 2016; 28 Omar (ref_20) 2010; 78 Jinesh (ref_30) 2018; 37 ref_8 David (ref_10) 2009; 2 Maleki (ref_31) 2017; 19 |
References_xml | – volume: 15 start-page: 18508 year: 2014 ident: ref_3 article-title: Effects of the olive-Derived poly phenol Oleuropein on human health publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms151018508 contributor: fullname: Barbaro – ident: ref_22 doi: 10.1186/1471-2407-7-80 – volume: 116 start-page: 8834 year: 2012 ident: ref_26 article-title: Bovine Serum Albumin Bioconjugated Gold Nanoparticles: Synthesis, Hemolysis, and Cytotoxicity toward Cancer Cell Lines publication-title: J. Phys. Chem. C doi: 10.1021/jp300585d contributor: fullname: Poonam – volume: 11 start-page: 4617 year: 2015 ident: ref_24 article-title: Oleuropein induces apoptosis via activation of caspases and suppression of phosphatidylinositol 3-kinase/protein kinase B pathway in HepG2 human hepatoma cell line publication-title: Mol. Med. Rep. doi: 10.3892/mmr.2015.3266 contributor: fullname: Yan – volume: 5 start-page: 20 year: 2015 ident: ref_28 article-title: Evaluation of the efficacy of magnetic nanoparticles of iron-loaded with platinum siscon breast cancer in vivo and in vitro studies publication-title: Mol. Biotechnol. contributor: fullname: Hosseinian – volume: 19 start-page: 412 year: 2017 ident: ref_31 article-title: Chromosomal Instability in Gastric Cancer Biology publication-title: Neoplasia doi: 10.1016/j.neo.2017.02.012 contributor: fullname: Maleki – volume: 139 start-page: 1327 year: 2009 ident: ref_7 article-title: Mutant p53 drives invasion by promoting integrin recycling publication-title: Cell doi: 10.1016/j.cell.2009.11.026 contributor: fullname: Muller – volume: 15 start-page: 563 year: 2005 ident: ref_15 article-title: How microRNAs control cell division, differentiation and death publication-title: Curr. Opin. Develop. doi: 10.1016/j.gde.2005.08.005 contributor: fullname: Miska – volume: 129 start-page: 1287 year: 2016 ident: ref_13 article-title: RAS isoforms and mutations in cancer at a glance publication-title: J. Cell Sci. doi: 10.1242/jcs.182873 contributor: fullname: Hobbs – volume: 280 start-page: 20059 year: 2005 ident: ref_29 article-title: Curcumin selectively induces apoptosis in deregulated cyclin D1expressed cells at the G2 phase of cell cycle in a p53-dependent manner publication-title: J. Biol. Chem. doi: 10.1074/jbc.M410670200 contributor: fullname: Choudhuri – volume: 9 start-page: 277 year: 2003 ident: ref_14 article-title: Uniform system for microRNA annotation publication-title: RNA doi: 10.1261/rna.2183803 contributor: fullname: Ambros – volume: 37 start-page: 839 year: 2018 ident: ref_30 article-title: Molecular genetics and cellular events of K-Ras-driven tumorigenesis publication-title: Oncogene doi: 10.1038/onc.2017.377 contributor: fullname: Jinesh – volume: 187 start-page: 433 year: 1999 ident: ref_11 article-title: Structural differences between valine-12 and aspartate-12 Ras proteins may modify carcinoma aggression publication-title: J. Pathol. doi: 10.1002/(SICI)1096-9896(199903)187:4<433::AID-PATH273>3.0.CO;2-E contributor: fullname: Going – volume: 18 start-page: 16 year: 2014 ident: ref_21 article-title: Antioxidant role of oleuropein on midbrain and dopaminergic neurons of substantia in aged rats publication-title: Iran. Biomed. J. contributor: fullname: Sarbishegi – volume: 12 start-page: 3223 year: 2015 ident: ref_5 article-title: Epigenetic alterations in gastric cancer publication-title: Mol. Med. Rep. doi: 10.3892/mmr.2015.3816 contributor: fullname: Fu – volume: 11 start-page: 753 year: 2010 ident: ref_12 article-title: Effects of KRAS, BRAF, NRAS and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: A retrospective consortium analysis publication-title: Lancet Oncol. doi: 10.1016/S1470-2045(10)70130-3 contributor: fullname: Claes – volume: 2 start-page: 18 year: 2009 ident: ref_10 article-title: Individualized therapies in colorectal cancer: KRAS as a marker for response to EGFR-targeted therapy publication-title: J. Hematol. Oncol. doi: 10.1186/1756-8722-2-18 contributor: fullname: David – volume: 119 start-page: 7151 year: 2018 ident: ref_18 article-title: Simultaneous downregulation of miR-21 and miR-155 through oleuropein for breast cancer prevention and therapy publication-title: J. Cell Biochem. doi: 10.1002/jcb.26754 contributor: fullname: Abtin – ident: ref_8 doi: 10.1186/1471-2407-8-255 – volume: 11 start-page: 1449 year: 2014 ident: ref_27 article-title: Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: Opportunities and challenges publication-title: Expert. Opin. Drug. Deliv. doi: 10.1517/17425247.2014.924501 contributor: fullname: Laurent – volume: 78 start-page: 133 year: 2010 ident: ref_20 article-title: Oleuropein in olive and its pharmacological effects publication-title: Sci. Pharm. doi: 10.3797/scipharm.0912-18 contributor: fullname: Omar – volume: 334 start-page: 769 year: 2005 ident: ref_19 article-title: Oleuropein, a non-toxic olive iridoid, is an anti-tumor agent and cytoskeleton disruptor publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2005.06.161 contributor: fullname: Hamdi – volume: 12 start-page: 354 year: 2006 ident: ref_1 article-title: Epidemiology of gastric cancer publication-title: World J. Gastroenterol. doi: 10.3748/wjg.v12.i3.354 contributor: fullname: Crew – volume: 28 start-page: 4978 year: 2016 ident: ref_23 article-title: Oleuropein inhibits the proliferation and invasion of glioma cells via suppression of the AKT signaling pathway publication-title: Oncol. Rep. contributor: fullname: Liu – volume: 28 start-page: 1617 year: 2017 ident: ref_4 article-title: Anticancer Properties of Phyto-Synthesized Silver Nanoparticles from Medicinal Plant Artemisia tschernieviana Besser Aerial Parts Extract Toward HT29 Human Colon Adenocarcinoma Cells publication-title: J. Clust. Sci. doi: 10.1007/s10876-017-1172-6 contributor: fullname: Khalili – volume: 37 start-page: e2015006 year: 2015 ident: ref_2 article-title: Stomach cancer incidence rates among Americans, Asian Americans and Native Asians from 1988 to 2011 publication-title: Epidemiol. Health doi: 10.4178/epih/e2015006 contributor: fullname: Kim – volume: 3 start-page: 63 year: 2011 ident: ref_16 article-title: Breast cancer and microRNAs: Therapeutic impact publication-title: Breast doi: 10.1016/S0960-9776(11)70297-1 contributor: fullname: Iorio – volume: 6 start-page: 34968 year: 2015 ident: ref_25 article-title: MiR-200c inhibits breast cancer proliferation by targeting KRAS publication-title: Oncotarget doi: 10.18632/oncotarget.5198 contributor: fullname: Song – volume: 18 start-page: 223 year: 2012 ident: ref_17 article-title: Cross Talk Between MicroRNA and Coding Cancer Genes publication-title: Cancer J. doi: 10.1097/PPO.0b013e318258b771 contributor: fullname: Kunej – volume: 26 start-page: 2031 year: 2005 ident: ref_6 article-title: Tumor suppressor genetics publication-title: Carcinogenesis doi: 10.1093/carcin/bgi223 contributor: fullname: Payne – volume: 5 start-page: 2606 year: 2006 ident: ref_9 article-title: Mutation analysis of 24 known cancer genes in the NCI-60 cell line set publication-title: Mol. Cancer Ther. doi: 10.1158/1535-7163.MCT-06-0433 contributor: fullname: Ikediobi |
SSID | ssj0032572 |
Score | 2.2982225 |
Snippet | Human gastric adenocarcinoma (AGS) is one of the most common malignant cancers worldwide. The present study aimed to transfer oleuropein into cancer cells... Background and objectives: Human gastric adenocarcinoma (AGS) is one of the most common malignant cancers worldwide. The present study aimed to transfer... Background and objectives: Human gastric adenocarcinoma (AGS) is one of the most common malignant cancers worldwide. The present study aimed to transfer... |
SourceID | doaj pubmedcentral proquest crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 388 |
SubjectTerms | Adenocarcinoma - prevention & control AGS Cancer Cell Proliferation - drug effects Gene Expression - drug effects Humans Iridoids - pharmacology Iridoids - therapeutic use K-Ras miR-200 oncogene nano-oleuropein Nanoparticles - therapeutic use Olea - enzymology Olea - genetics oleuropein Proto-Oncogene Proteins p21(ras) - biosynthesis Proto-Oncogene Proteins p21(ras) - blood real-time PCR Spectrometry, X-Ray Emission - methods Stomach Neoplasms - prevention & control |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LatwwFBUli9BNadOX0wcqdNOFiPWype6mQ9LQMk3pNJCdkSy5MUzkMvZA8_e5sjwhEwrddGsLLHSPpHN9pXMQem-MKBTnUQ9PSiKcUURRLkleK2cboBRmdGtYfCtOz8WXC3lxx-ornglL8sBp4I5qxq3kZQOTUonoJkm9L5mStnC51XXS-cz1NplKazAHILJUlOSQ1B9NdWoTxbui_MnOJjRq9f-NYN4_J3ln4zl5jB5NjBHPUk-foAc-HKD9xVQTf4o2y-sALK5ve9w1GFbLjnw3a3NlfoV4QRGfrfz4x70NeOhwtOqoPf76Y7bEZwBjcvxnOgobPuIZhjUPL3y8Ddz2V6n9ZWvbAc8-L_E8ImSN53616p-h85Pjn_NTMpkpkFoUbCDSK-maqMYunTZMSG2asvRUOplTZ3OloV3DLeNCeMZqCG5phXbSc8joypo_R3uhC_4lwpZSbW3hG6-sENEQUEhhgHsUVDkt8gx92I5u9TtpZlSQa8RIVPcjkaFPcfhv20W16_EBYKCaMFD9CwMZercNXgWzI5Y8TPDdpq8Yg71XUEF1hl6kYN5-ikN6DgRTZKjcCfNOX3bfhPZyVOAuChVt2g__R-dfoYdAwuJNMkL1a7Q3rDf-DRCdwb4dMX0DX_j66A priority: 102 providerName: Directory of Open Access Journals |
Title | Synthesis of Nano-Paramagnetic Oleuropein to Induce KRAS Over-Expression: A New Mechanism to Inhibit AGS Cancer Cells |
URI | https://www.ncbi.nlm.nih.gov/pubmed/31330954 https://search.proquest.com/docview/2271841419 https://pubmed.ncbi.nlm.nih.gov/PMC6681187 https://doaj.org/article/c23b537f9118457591ee7285b6d0b9c3 |
Volume | 55 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9tAEB6SFEIupe-qD7OFXnpQLGkfWvXmGKehxYmJG_BN7EqrRGCvgiVD--87q0eoQ0-9Siu0aD7NfrMz-w3AZ6WYkJQ6PTzOfZYr6cuQcj_IZK4LpBSq7dYwvxQXN-z7iq8OgA9nYdqi_UyXp3a9ObXlXVtbeb_JxkOd2HgxnwohXZfs8SEcIkCHEL1zvxQx2KU40cEIEay63CTF2H7cp6uV0_ByKigncEwxRkOWwfaWpVa9_1-U83Hl5F9L0fkzeNpzSDLp5vocDox9AcfzPkv-EnbL3xZ5XV3WpCoI-s_KX6it2qhb644skqu1affgS0uairjmHZkhP64nS3KFwPZnv_riWPuVTAh6QTI37nxwWW-68XelLhsy-bYkU4eZLZma9bp-BTfns5_TC79vr-BnTESNz43keeH02XmeqIjxRBVxbEKe8yDMdSATHFdQHVHGTBRlaO5YsyTnhmKMF2f0NRzZypq3QHQYJloLUxipGXMtAhlnCtmICGWesMCDL8PXTe87FY0Uow9nlPSxUTw4c5__YZzTv24vVNvbtEdBmkVUcxoX6Kolcz1GQ2PiSHIt8kAnGfXg02C8FP8XlwRR1lS7Oo0iXI1ZyMLEgzedMR9eNYDBg3jPzHtz2b-DEG01uXtIvvvvJ9_DCXIxd6DMD5MPcNRsd-Yj8p1GjxDlq3gET85ml4vrUbtrMGox_wdAbAHG |
link.rule.ids | 230,315,730,783,787,867,888,2109,27936,27937,31732,33757,53804,53806 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB6VIpVeeD_Mc5G4cHBiex9ecwtRS6BNW5EW5Wbt2uvWIrGr2JGAX8-sHxWJuMDVu5a9nm92Zzwz3wC8U4oJSanlw-PcZamSrvQpd71EpjpDk0I13RqmJ2Jywb7M-XwHeF8L0yTtJzofFIvloMivmtzK62Uy7PPEhmfTsRDSdske3oLbqK8e6530dgOmiMI2yIlbjBDevI1OUvTuh13AWlkWL8uDsg97FL00tDPYxsHU8Pf_zejczp384zA6vAff-mW0OSjfB-taD5JfWwyP_7zO-3C3M0_JqB1-ADumeAh70y4A_wjWs58FmoxVXpEyI7g1l-6ZWqmluixsNSQ5XZjm935ekLokti9IYsjR19GMnKLOuAc_urzb4gMZEdxgydTY0uO8Wrbzr3Kd12T0aUbGFo4rMjaLRfUYLg4PzscTt-vc4CZMBLXLjeRpZqnfeRqpgPFIZWFofJ5yz0-1JyOcl1EdUMZMECSIpFCzKOWGovsYJvQJ7BZlYZ4B0b4faS1MZqRmzHYfZJwpNHSEL9OIeQ6878UWX7cEHTE6Nlba8ba0Hfho5Xozz1JrNxfK1WXcffg4CajmNMzwFJDMti_1jQkDybVIPR0l1IG3PSpiVEUbX1GFKddVHAR40DOf-ZEDT1uU3DyqR5kD4QZ-Nt5lcwRR0dB9dyh4_t93voE7k_PpcXz8-eToBeyjyWfr1lw_egm79WptXqFZVevXjRL9BjNrIEs |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9NAFB5BkaJe2BezDhIXDo49nsVjbiE0FEraiFAp4mLN2OPWIrGj2JGAX88bL1UTcerVHsvL-97m9-Z7CL1TiglJqeXD49xlqZKuJJS7fiJTnUFIoZppDdNTcXzOvi744tqor6ZpP9H5sFiuhkV-2fRWrleJ1_eJebPpWAhpp2R76zTzbqM7oLO-6BP11ghTQGJb6AQzI4S_aCuUFDJ8rytaK8vkZblQDtGAQqYGsQbbcU4Nh___As_9_slrDmlyD_3sX6XtQ_k13NZ6mPzdY3m80bveR3e7MBWP2iUP0C1TPESDaVeIf4S28z8FhI5VXuEyw2CiS3emNmqlLgq7KxKfLU3zmz8vcF1iOx8kMfjk-2iOz0B33KPfXf9t8QGPMBhaPDV2C3Jerdr1l7nOazz6PMdjC8sNHpvlsnqMzidHP8bHbjfBwU2YCGqXG8nTzFLA8zRSAeORysLQEJ5yn6TalxGsy6gOKGMmCBJAVKhZlHJDIY0ME_oEHRRlYZ4hrAmJtBYmM1IzZqcQMs4UBDyCyDRivoPe96KL1y1RRwwJjpV4vC9xB320sr1aZym2mwPl5iLuPn6cBFRzGmbgDSSzY0yJMWEguRapr6OEOuhtj4wYVNLWWVRhym0VBwE4fEYYiRz0tEXK1a16pDko3MHQzrPsngFkNLTfHRKe3_jKN2gw-zSJv305PXmBDiHys9vXXBK9RAf1ZmteQXRV69eNHv0DP0siyw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Synthesis+of+Nano-Paramagnetic+Oleuropein+to+Induce+KRAS+Over-Expression%3A+A+New+Mechanism+to+Inhibit+AGS+Cancer+Cells&rft.jtitle=Medicina+%28Kaunas%2C+Lithuania%29&rft.au=Farhad+Barzegar&rft.au=Mohammad+Zaefizadeh&rft.au=Reza+Yari&rft.au=Ali+Salehzadeh&rft.date=2019-07-19&rft.pub=MDPI+AG&rft.eissn=1010-660X&rft.volume=55&rft.issue=7&rft.spage=388&rft_id=info:doi/10.3390%2Fmedicina55070388&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_c23b537f9118457591ee7285b6d0b9c3 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1648-9144&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1648-9144&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1648-9144&client=summon |